NNK reduction pathway gene polymorphisms and risk of lung cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-2744|54|S1|E94-E102

ISSN： 0899-1987

Source： Molecular Carcinogenesis, Vol.54, Iss.S1, 2015-06, pp. : E94-E102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of metallothionein gene polymorphisms on the risk of lung cancer in a Japanese population

By  

Molecular Carcinogenesis, Vol. 54, Iss. S1, 2015-06 ,pp. : E122-E128

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association between polymorphisms in the GSTA4 gene and risk of lung cancer: A case–control study in a Southeastern Chinese population

By  

Molecular Carcinogenesis, Vol. 48, Iss. 3, 2009-03 ,pp. : 253-259

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer

By  

Molecular Carcinogenesis, Vol. 57, Iss. 2, 2018-02 ,pp. : 216-224

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic polymorphisms in the microRNA binding‐sites of the thymidylate synthase gene predict risk and survival in gastric cancer

By  

Molecular Carcinogenesis, Vol. 54, Iss. 9, 2015-09 ,pp. : 880-888

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interleukin polymorphisms associated with overall survival, disease‐free survival, and recurrence in non‐small cell lung cancer patients

By  

Molecular Carcinogenesis, Vol. 54, Iss. S1, 2015-06 ,pp. : E172-E184

John Wiley & Sons Inc

Access to resources Recommend Favorite